Inspire Medical Systems (INSP) Tops Q3 EPS by 58c, provides guidance

Inspire Medical Systems (NYSE: INSP) reported Q3 EPS of $0.38, $0.58 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $224.5 million versus the consensus estimate of $220.42 million.

GUIDANCE:

Inspire Medical Systems sees FY2025 EPS of $0.90-$1.00, versus the consensus of $0.99. Inspire Medical Systems sees FY2025 revenue of $900-910 million, versus the consensus of $903.6 million.

For earnings history and earnings-related data on Inspire Medical Systems (INSP) click here.

You May Also Be Interested In

• Goldman Sachs Upgrades China Resources Microelectronics Ltd (688396:CH) to Neutral
• Goldman Sachs Starts Chagee Holdings (CHA) at Neutral
• Morgan Stanley Downgrades Sands China Ltd. (1928:HK) (SCHYY) to Equalweight